Latest News about BNTX
Recent news which mentions BNTX
From Benzinga
The Worst Mistake Pfizer Investors Can Make in 2022
December 23, 2021
From Motley Fool
Why BioNTech, Novavax, and Ocugen Stocks Are Slipping Today
December 22, 2021
From Motley Fool
Why Pfizer Stock Is Sinking Today
December 21, 2021
From Motley Fool
3 Great Stocks to Buy With the Omicron Variant Spreading Like Wildfire
December 21, 2021
From Motley Fool
Why Some Coronavirus Stocks Plunged Today
December 20, 2021
From Motley Fool
MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?
December 20, 2021
From InvestorPlace
Data suggests boosters essential to avoid omicron infection, and Fauci says best way to protect kids is make sure adults around them are fully vaccinated
December 20, 2021
From MarketWatch
Dr. Francis Collins, National Institutes of Health outgoing director: ‘Nobody was expecting omicron. This one really was a curveball.’
December 20, 2021
From MarketWatch
3 Biotech Stocks That Soared in 2021 and Could Go Even Higher in 2022
December 19, 2021
From Motley Fool
Can Omicron Variant Antibodies Protect From Other Covid-19 Variants?
December 18, 2021
From Motley Fool
Is This New Data on Valneva's Less-Effective Booster Concerning?
December 18, 2021
From Motley Fool
Why Pfizer and Johnson & Johnson Fell on Friday
December 17, 2021
From Motley Fool
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
Why Moderna and Pfizer Beat the Market Today
December 16, 2021
From Motley Fool
Why Novavax, BioNTech, and Moderna Stocks Are Jumping This Week
December 16, 2021
From Motley Fool
Why Arcturus Therapeutics Stock Was Up 16% Thursday
December 16, 2021
From Motley Fool
From Benzinga
3 Stocks That Just Declared Dividend Raises
December 16, 2021
From Motley Fool
While Novavax Stock Remains Cursed, It Might Be Time to Buy
December 16, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.